The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metformin use and outcomes among breast cancer patients on immunotherapy: Insights from a real-world cohort.
 
Kevin Kensler
No Relationships to Disclose
 
Faith Morley
No Relationships to Disclose
 
Sadna Budhu
No Relationships to Disclose
 
Zihui Chen
No Relationships to Disclose
 
Lejing Li
No Relationships to Disclose
 
Yael Yossefy
No Relationships to Disclose
 
Taha Merghoub
Stock and Other Ownership Interests - Imvaq Therapeutics
Consulting or Advisory Role - Daiichi Sankyo; ImmunOs Therapeutics; LIfT Biosciences; Normunity; Pfizer; TigaTx
Research Funding - Adaptive Biotechnologies; Aprea Therapeutics; Bristol-Myers Squibb; Enterome; Infinity Pharmaceuticals; Kyn Therapeutics; Leap Therapeutics; Peregrine Pharmaceuticals; Realta Life Sciences; Surface Oncology
Patents, Royalties, Other Intellectual Property - patent applications related to work on oncolytic viral therapy, alpha virus–based vaccine, neo antigen modelling, immunomodulatory nanoparticles , bi-specific activators, FLT3L, CD40, GITR, OX40, PD-1, CTLA-4, and chimeric receptors targeting melanoma dif; U.S. Provisional Patent Application (Ser. No. 63/888,188) related to work on CD47 and TSP-1
 
Laura Pinheiro
Employment - Johnson and Johnson (I)
Stock and Other Ownership Interests - Johnson and Johnson (I)
Research Funding - Pfizer (Inst)